<DOC>
	<DOCNO>NCT00298818</DOCNO>
	<brief_summary>The purpose study assess efficacy tolerability `` real-world '' clinical practice , adjunctive zonisamide treatment adult patient developmental disability epilepsy .</brief_summary>
	<brief_title>Open Label Study Zonisamide Treatment Epilepsy Patients With Mental Retardation</brief_title>
	<detailed_description>While number randomize double-blind controlled trial demonstrate value zonisamide treatment seizure , study lend limited insight efficacy tolerance zonisamide real-world clinical practice . Furthermore , randomize trial tend inquire negative effect , adverse reaction , positive effect improvement mood , sense well-being similarly categorize . In addition , little information experience zonisamide specifically adult patient mental retardation ( MR ) / developmental disability ( DD ) . Anecdotal experience suggest zonisamide exceptionally well-tolerated , associate improved general sense well-being quality life non-DD patient . In patient MR/DD , observational study promote awareness distinguish feature aspect efficacy essential guide decision-making prescribing antiepileptic drug .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<criteria>Male Female , least 18 year age Diagnosis mental retardation Uncontrolled seizure intolerable side effect current AEDs Legal guardian able consent Sulfa allergy Prior exposure zonisamide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Mental Retardation</keyword>
	<keyword>Developmental Disabilities</keyword>
</DOC>